Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain

Abstract

There are scarce data of the costs of non-small cell lung cancer (NSCLC) recurrence in Spain. The objective of this study is to assess the economic burden of disease recurrence, for both locoregional and/or metastatic relapses, after appropriate early-stage NSCLC treatment in Spain.